Citigroup reiterates Sepracor at buy

Sepracor was reiterated by Citigroup Investment Research analyst Andrew Swanson at buy. The company will report its fourth-quarter results on Jan. 31 before the market opens. Citigroup forecasts earnings of $0.09 per share, ahead of the $0.04 consensus view and the $0.33 loss the company reported in the fourth quarter of 2004. Guidance will be the real focus. Shares of the Marlborough, Mass., pharmaceutical company were down 61 cents, or 1.24%, at $48.45 on volume of 2,882,998 shares versus the three-month running average of 1,770,030 shares. (Nasdaq: SEPR)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.